453O DS-7300 (B7-H3 DXd antibody-drug conjugate [ADC]) shows durable antitumor activity in advanced solid tumors: Extended follow-up of a phase I/II study

T. Doi, Minesh Patel, G.S. Falchook, T. Koyama, C.F. Friedman, S. Piha-Paul, M.E. Gutierrez, R. Abdul-Karim, M. Awad, D.R. Adkins,

Annals of Oncology · 2022 · 39 citations · 0 references

Concepts